Inclusion criteria | |
I. Definite IE, according to modified ESC 2015 criteria [6], caused by gram-positive cocci (staphylococci, streptococci and enterococci), including native, prosthetic valve IE and cardiac device-related IE. | |
II. 18 years old or older. | |
III. Absence of fever, microbiological or analytical findings suggesting persistent infection in the last 24 h prior to randomization. | |
IV. Absence of locally uncontrolled infection signs (abscess, pseudoaneurysm, fistula, enlarging vegetation) at randomization, confirmed by recent transesophageal echocardiography (performed within 48 h of randomization). | |
V. Women of childbearing potential who will agree to the use of effective contraceptive methods while on antibiotic treatment. | |
Exclusion criteria | |
I. Patients who have received appropriate parenteral antibiotic therapy for infective endocarditis for more than 12 days. | |
II. Patients not suitable to be discharged after 10 days of conventional treatment, due to clinical reasons (sequels of stroke that prevent discharge, progressive renal failure, hepatic failure, heart failure). | |
III. Patients receiving chemotherapy or immunosuppressive therapy. | |
IV. Pregnant or breastfeeding women. | |
V. Need of prolonged antibiotic therapy due to spondylodiscitis or other septic complication. | |
VI. Absence of patient’s ability or commitment to continue follow-up after being discharged from hospital. | |
VII. Inability to give informed consent to participation. | |
VIII. Cognitive impairment or lack of language skills needed to complete the questionnaires. | |
IX. Patients who meet urgent cardiac surgery ESC criteria but are considered inoperable due to high surgical risk. |